| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.SCHRES.2006.03.034 |
| P698 | PubMed publication ID | 16650735 |
| P50 | author | Thomas McGlashan | Q7792302 |
| P2093 | author name string | Scott W Woods | |
| Tandy J Miller | |||
| Joanna L Rosen | |||
| Jennifer T D'Andrea | |||
| P433 | issue | 1-3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| patient | Q181600 | ||
| schizophrenic prodrome | Q5840516 | ||
| P304 | page(s) | 124-131 | |
| P577 | publication date | 2006-05-02 | |
| P1433 | published in | Schizophrenia Research | Q7431607 |
| P1476 | title | Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome. | |
| P478 | volume | 85 |
| Q35537375 | Actigraphic-measured sleep disturbance predicts increased positive symptoms in adolescents at ultra high-risk for psychosis: A longitudinal study |
| Q38760501 | Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up |
| Q37017300 | Anxiety in youth at clinical high risk for psychosis |
| Q34644978 | Attenuated psychosis and the schizophrenia prodrome: current status of risk identification and psychosis prevention |
| Q38114987 | Attitudes of patients and clinicians in relation to the at-risk state for psychosis |
| Q91669884 | Borderline Personality Pathology in an At Risk Mental State Sample |
| Q47658050 | Borderline personality features and development of psychosis in an 'ultra high risk' (UHR) population: a case control study |
| Q48089122 | Borderline personality pathology in young people at ultra high risk of developing a psychotic disorder |
| Q50041332 | Can We Predict Psychosis Outside the Clinical High-Risk State? A Systematic Review of Non-Psychotic Risk Syndromes for Mental Disorders. |
| Q57519894 | Can antidepressants prevent psychosis? |
| Q48576732 | Can cognitive deficits facilitate differential diagnosis between at-risk mental state for psychosis and depressive disorders? |
| Q37259866 | Cannabis and Psychosis: What Can Daily Diaries Tell Us About Who is Vulnerable? |
| Q37710469 | Cerebello-thalamo-cortical networks predict positive symptom progression in individuals at ultra-high risk for psychosis |
| Q33694980 | Childhood onset diagnoses in a case series of teens at clinical high risk for psychosis |
| Q50561525 | Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats. |
| Q35012476 | Clinical characteristics in schizophrenia patients with or without suicide attempts and non-suicidal self-harm--a cross-sectional study |
| Q92105678 | Comorbid Personality Disorders in Individuals With an At-Risk Mental State for Psychosis: A Meta-Analytic Review |
| Q38124448 | Comorbid substance use disorder in schizophrenia: a selective overview of neurobiological and cognitive underpinnings |
| Q34123531 | Current status specifiers for patients at clinical high risk for psychosis |
| Q37383381 | Diagnosis and treatment of a patient with both psychotic and obsessive-compulsive symptoms |
| Q47445601 | Duration of untreated psychosis and pathway to care in Riyadh, Saudi Arabia |
| Q51901709 | Early psychosis: where we've been, where we still have to go. |
| Q34095720 | Early signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disorders |
| Q39820721 | Effects of Δ-THC on Working Memory: Implications for Schizophrenia? |
| Q45247344 | Examining the course and outcome of individuals diagnosed with schizophrenia and comorbid borderline personality disorder |
| Q45713567 | First self-perceived signs and symptoms in emerging psychosis compared with depression |
| Q37417937 | Gender difference in the prodromal symptoms of first-episode schizophrenia. |
| Q35768242 | Identification and characterization of prodromal risk syndromes in young adolescents in the community: a population-based clinical interview study |
| Q36303876 | Interventions for youth at high risk for bipolar disorder and schizophrenia |
| Q47596285 | Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups |
| Q36817252 | Mapping Depression in Schizophrenia: A Functional Magnetic Resonance Imaging Study |
| Q36767810 | Neurocognition and conversion to psychosis in adolescents at high-risk |
| Q91705551 | Nicotine consumption during the prodromal phase of schizophrenia - a review of the literature |
| Q38191255 | Obsessive-compulsive symptoms in at-risk mental states for psychosis: associations with clinical impairment and cognitive function |
| Q39599401 | Offending prior to first psychiatric contact: a population-based register study |
| Q91722923 | Onset of schizophrenia diagnoses in a large clinical cohort |
| Q50772109 | Personality disorders and accentuations in at-risk persons with and without conversion to first-episode psychosis. |
| Q89692219 | Physical Illnesses Before Diagnosed as Schizophrenia: A Nationwide Case-Control Study |
| Q39824871 | Polish individuals with an at-risk mental state: demographic and clinical characteristics |
| Q34376032 | Practitioner review: schizophrenia spectrum disorders and the at-risk mental state for psychosis in children and adolescents--evidence-based management approaches |
| Q37682795 | Prediction and prevention of the first psychotic episode: new directions and opportunities. |
| Q34586836 | Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America |
| Q33677429 | Prevalence of attenuated psychotic symptoms and their relationship with DSM-IV diagnoses in a general psychiatric outpatient clinic |
| Q92917669 | Prodromes and Preclinical Detection of Brain Diseases: Surveying the Ethical Landscape of Predicting Brain Health |
| Q33939659 | Prognosis of schizophrenia in persons with and without a history of cannabis use. |
| Q47745092 | Psychopathology and social functioning of 42 subjects from a Danish ultra high-risk cohort |
| Q30650589 | Psychotropic medication use in youth at high risk for psychosis: comparison of baseline data from two research cohorts 1998-2005 and 2008-2011 |
| Q40182037 | Racial discrimination is associated with distressing subthreshold positive psychotic symptoms among US urban ethnic minority young adults |
| Q35176725 | Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of ps |
| Q33662861 | Reasons for cannabis use among youths at ultra high risk for psychosis. |
| Q34698891 | Reduced P300 amplitude during retrieval on a spatial working memory task in a community sample of adolescents who report psychotic symptoms. |
| Q53159612 | Reduced subjective quality of life in persons at risk for psychosis. |
| Q30475598 | Research in people with psychosis risk syndrome: a review of the current evidence and future directions |
| Q93051241 | Screening nursing students to identify those at high risk of poor mental health: a cross-sectional survey |
| Q37374981 | Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis |
| Q36831744 | Social cognition as an RDoC domain |
| Q35950862 | Specificity of Incident Diagnostic Outcomes in Patients at Clinical High Risk for Psychosis |
| Q37705759 | Stress-induced dopamine response in subjects at clinical high risk for schizophrenia with and without concurrent cannabis use |
| Q38756852 | Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study |
| Q34669646 | Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms |
| Q37036013 | Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis |
| Q50714088 | The 'at-risk mental state' for psychosis in adolescents: clinical presentation, transition and remission. |
| Q46425024 | The distribution of self-reported psychotic-like experiences in non-psychotic help-seeking mental health patients in the general population; a factor mixture analysis |
| Q55515865 | The impact of psychotic experiences in the early stages of mental health problems in young people. |
| Q90133833 | The latent structure of depressive symptoms across clinical high risk and chronic phases of psychotic illness |
| Q36037530 | The relationship of social function to depressive and negative symptoms in individuals at clinical high risk for psychosis |
| Q58791628 | The transition from child and adolescent to adult mental health services with a focus on diagnosis progression |
| Q37310198 | Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study |
| Q53226034 | Vulnerability to psychosis increases the risk of depression. Results of the RADEP study. |
| Q48374788 | Where will insights into hippocampal activity in schizophrenia lead us? |
Search more.